Latest acute leukemia Stories
SAN DIEGO and TORONTO, March 3, 2015 /PRNewswire/ - Aptose Biosciences Inc.
SALT LAKE CITY, Feb.
BEVERLY HILLS, Calif., Feb. 23, 2015 /PRNewswire/ -- Rich Pharmaceuticals, Inc.
A new protein-based treatment could help treat acute lymphoblastic leukemia (ALL) patients whose cancer cells have developed resistance to contemporary chemotherapy, according to new research published online Monday in the Journal of Clinical Investigation.
The leukemia therapeutics market report gives the detailed analysis on the major market drivers, restraints, and opportunities in North America, & Europe.
EWING, N.J., Jan. 20, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
- Data Show Significant Survival Improvement with CPX-351 in Poor-Risk Patients - EWING, N.J., Jan. 12, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc.
SEATTLE, Jan. 12, 2015 /PRNewswire/ -- CTI BioPharma Corp. (CTI BioPharma) (NASDAQ and MTA: CTIC) announced today the appointment of Alan K.
SEATTLE, Jan. 8, 2015 /PRNewswire/ -- CTI BioPharma Corp.
- A person or thing gazed at with wonder or curiosity, especially of a scornful kind.